Early and accurate diagnosis is crucial for managing neurodegenerative diseases. Nanotechnology offers innovative solutions for early detection through the development of biosensors and nanoprobes. These nanoscale devices can detect biomarkers at very low concentrations, allowing for earlier diagnosis than traditional methods. For example, quantum dots and gold nanoparticles have been used to identify amyloid plaques in Alzheimer’s disease at much earlier stages.
